Osmotica Pharmaceuticals plc IPO Research Information

Osmotica Pharmaceuticals plc IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Osmotica Pharmaceuticals plc, and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Osmotica Pharmaceuticals plc	OSMT - NASDAQ	$14.00-$16.00	$7.00	$9.00	6.65 million	10/18/2018
Underwriter(s): Jefferies, Barclays, RBC, Wells Fargo
Co-Manager(s):
Industry: Health Care
Filing(s): Filed 2018-09-14 Terms Added 2018-10-01 Terms Changed 2018-10-17

Osmotica Pharmaceuticals plc Quote & Chart - Click for current quote - OSMT

About Osmotica Pharmaceuticals plc (adapted from Osmotica Pharmaceuticals plc prospectus):
They are a fully integrated biopharmaceutical company focused on the development and commercialization of specialty products that target markets with underserved patient populations.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "OSMT" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.